The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.
Also called NCT05350124
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 160 participants
- Sponsor
- King Abdulaziz University
- Registry
-
NCT05350124
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT05350124. Randomized; triple masking; primary purpose treatment. Start 2022-11 (anticipated); primary completion 2023-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis
- Condition
- Restless Legs Syndrome
- Condition
- End Stage Renal Disease
- Intervention (Drug)
- Ascorbic acid
- Intervention (Drug)
- Tocopherol
- Intervention (Drug)
- Placebo capsule
- Intervention (Drug)
- Placebo capsule
- Lead sponsor
- King Abdulaziz University
Record details
- Record id
cardio:ct-nct05350124- Content hash
6bf0bd995a8968aa9c909e5d03ebe88e05254169a3a590a89f3a1810c22d8817